Clinical TrialsSearch results
Number of results: 875
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01
Other
- A randomized clinical trial of adjuvant chemotherapy with TS-1 versus UFT following curative operation for Stage III colorectal cancer
- stage III colorectal cancer
- Boso Clinical Oncology Group
- 2006-04-01
Other
- A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancer
- stage III colorectal cancer
- Boso Clinical Oncology Group
- 2008-12-10
Other
- Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)
- Stage III colorectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Completed
- Adjuvant Chemotherapy for colon cancer with HIgh EVidencE(JFMC47-1202-C3: ACHIEVE Trial)
- stage III colon cancer (including rectosigmoid cancer)
- Yoshino Takayuki
- 2019-02-18
Other
- Mesorectal excision with lateral lymph node dissection versus without lateral lymph node dissection for clinical stage II, III lower rectal cancer(JCOG0212)
- Stage II, III lower rectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-01
Not yet recruiting
- A Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Trastuzumab Deruxtecan for Patients with Stages II-III HER2-Amplified or HER2-Mutant Non-Small Cell Lung Cancers
- Stage II-III HER2-Amplified or HER2-Mutant Non-Small Cell Lung Cancer
- Tsuboi Masahiro
- 2024-12-09
Other
- The safety and efficacy trial of primary chemo-radiotherapy for stage I to IIIA breast cancer (JCOG0306)
- stage I to IIIA breast cancer
- Japan Clinical Oncology Group
- 2005-09-05
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21